A pharmacokinetic comparison of adult and pediatric formulations of raltegravir in healthy adults.
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2014
Price : $35 *
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Merck & Co
- 15 Apr 2014 New trial record
- 07 Mar 2014 Results published in the Antiviral Therapy.